NNBP — Nanobac Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $4.12m
- $0.02m
Annual income statement for Nanobac Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2003 December 31st | C2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB/A | 10KSB | 10KSB | 10KSB | 10KSB |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.483 | 0.358 | 0.657 | 0.225 | 0.018 |
| Cost of Revenue | |||||
| Gross Profit | 0.15 | 0.258 | 0.428 | 0.145 | 0.003 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3.18 | 8.6 | 4.21 | 5.04 | 6.49 |
| Operating Profit | -2.7 | -8.24 | -3.56 | -4.82 | -6.47 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.76 | -8.46 | -3.69 | -4.97 | -6.58 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.76 | -8.46 | -3.69 | -4.97 | -6.58 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -3.7 | -8.52 | -3.69 | -4.97 | -6.58 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -3.7 | -8.52 | -3.69 | -4.97 | -6.58 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.041 | -0.051 | -0.016 | -0.022 | -0.02 |
| Dividends per Share |